CurrentEndo
Get Weekly

CurrentEndo coverage · page 15 of 18

Osteoporosis International

Briefs 561–600 of 695 CurrentEndo has covered from this journal, newest publication first

Latest from Osteoporosis International

All coverage, newest first

  1. Osteoporos Int

    A genome-wide genomic score added to standard recommended stratification tools does not improve the identification of patients with very low bone mineral density

    Diagnostic or prognostic studyBone & mineral

  2. Osteoporos Int

    Comparison of anti-fracture effectiveness of zoledronate, ibandronate and alendronate versus denosumab in a registry-based cohort study

    Cohort studyBone & mineral

  3. Osteoporos Int

    Drug adherence and treatment duration for denosumab and mortality risk among hip fracture patients

    Cohort studyBone & mineral

  4. Osteoporos Int

    Drug utilization analysis of osteoporosis medications in seven European electronic health databases

    Cohort studyBone & mineral

  5. Osteoporos Int

    Does adding exercise or physical activity to pharmacological osteoporosis therapy in patients with increased fracture risk improve bone mineral density and lower fracture risk? A systematic review and meta-analysis

    Meta-analysisBone & mineral

  6. Osteoporos Int

    Efficacy and safety of tai chi exercise on bone health: An umbrella review

    Research articleReproductive endocrine

  7. Osteoporos Int

    Development, implementation and evaluation of a multinational FLS mentorship programme in Latin America

    Research articleBone & mineral

  8. Osteoporos Int

    Update on the clinical use of trabecular bone score (TBS) in the management of osteoporosis: results of an expert group meeting organized by the European Society for Clinical and Economic Aspects of Osteoporosis, Osteoarthritis and Musculoskeletal Diseases (ESCEO), and the International Osteoporosis Foundation (IOF) under the auspices of WHO Collaborating Center for Epidemiology of Musculoskeletal Health and Aging

    Guideline or statementBone & mineral

  9. Osteoporos Int

    Liver enzyme inducing anticonvulsant drug use is associated with prevalent vertebral fracture

    Cross-sectional studyBone & mineral

  10. Osteoporos Int

    Real-world evidence: new opportunities for osteoporosis research. Recommendations from a Working Group from the European Society for Clinical and Economic Aspects of Osteoporosis, Osteoarthritis and Musculoskeletal Diseases (ESCEO)

    Guideline or statementBone & mineral

  11. Osteoporos Int

    Establishing a Chinese older hip fracture registry for older patients: a Delphi study to define the focus and key variables for this registry

    Guideline or statementBone & mineral

  12. Osteoporos Int

    Impact of fragility fractures on activities of daily living and productivity in community-dwelling women: a multi-national study

    Cross-sectional studyBone & mineral

  13. Osteoporos Int

    Comorbidity and risk of infection among patients with hip fracture: a Danish population-based cohort study

    Cohort studyBone & mineral

  14. Osteoporos Int

    Risk comparison of osteonecrosis of the jaw in osteoporotic patients treated with bisphosphonates vs. denosumab: a multi-institutional retrospective cohort study in Taiwan

    Cohort studyBone & mineral

  15. Osteoporos Int

    Causal relationship between type 2 diabetes mellitus and bone mineral density: a Mendelian randomization study in an East Asian population

    Research articleBone & mineral

  16. Osteoporos Int

    Improving care pathways for people living with rare bone diseases (RBDs): outcomes from the first RBD Summit

    Guideline or statementBone & mineral

  17. Osteoporos Int

    Research priorities regarding the use of bisphosphonates for osteoporosis: a UK priority setting exercise

    Research articleBone & mineral

  18. Osteoporos Int

    Urinary pentosidine level is associated with the risk of fracture in community-dwelling older adults: a prospective observational study

    Cohort studyBone & mineral

  19. Osteoporos Int

    Zoledronic acid after spinal cord injury mitigates losses in proximal femoral strength independent of ambulation ability

    Randomized controlled trialBone & mineral

  20. Osteoporos Int

    Osteoporosis medication adherence tools: a systematic review

    Meta-analysisBone & mineral

  21. Osteoporos Int

    Imaging of pelvic ring fractures in older adults and its clinical implications-a systematic review

    Meta-analysisBone & mineral

  22. Osteoporos Int

    Association between bisphosphonate use and stroke risk: a meta-analysis

    Meta-analysisBone & mineral

  23. Osteoporos Int

    The impact of acute-phase reaction on mortality and re-fracture after zoledronic acid in hospitalized elderly osteoporotic fracture patients

    Cohort studyBone & mineral

  24. Osteoporos Int

    Mortality among older adults with osteoporotic vertebral fracture

    Cohort studyBone & mineral

  25. Osteoporos Int

    Relationships between longitudinal changes in body composition and bone mineral density in middle-to-older aged Australians

    Cohort studyBone & mineral

  26. Osteoporos Int

    Acromegaly and the long-term fracture risk of the vertebra and hip: a national cohort study

    Cohort studyPituitary

  27. Osteoporos Int

    Low bone mineral density, a neglected condition in North Africa and Middle East: estimates from the Global Burden of Disease Study, 1990–2019

    Secondary analysisBone & mineral

  28. Osteoporos Int

    Clinical characteristics of pregnancy and lactation associated osteoporosis: An online survey study

    Cross-sectional studyBone & mineral

  29. Osteoporos Int

    Association of C-peptide level with bone mineral density in type 2 diabetes mellitus

    Cross-sectional studyT2D & other

  30. Osteoporos Int

    Comparison of bone microstructure and strength in the distal radius and tibia between the different types of primary hypertrophic osteoarthropathy: an HR-pQCT study

    Cross-sectional studyBone & mineral

  31. Osteoporos Int

    Development and validation of common data model-based fracture prediction model using machine learning algorithm

    Diagnostic or prognostic studyBone & mineral

  32. Osteoporos Int

    The impact of prior fragility fractures on long-term periprosthetic fracture risk following total knee arthroplasty

    Cohort studyBone & mineral

  33. Osteoporos Int

    Trends in incidence of recorded diagnosis of osteoporosis, osteopenia, and fragility fractures in people aged 50 years and above: retrospective cohort study using UK primary care data

    Cohort studyBone & mineral

  34. Osteoporos Int

    Heel quantitative ultrasound (QUS) predicts incident fractures independently of trabecular bone score (TBS), bone mineral density (BMD), and FRAX: the OsteoLaus Study

    Cohort studyBone & mineral

  35. Osteoporos Int

    Protein intake and bone health: an umbrella review of systematic reviews for the evidence-based guideline of the German Nutrition Society

    Guideline or statementBone & mineral

  36. Osteoporos Int

    Effects of intermittent or single high-dose vitamin D supplementation on risk of falls and fractures: a systematic review and meta-analysis

    Meta-analysisBone & mineral

  37. Osteoporos Int

    Trends in incidence, health care consumption, and costs for proximal femoral fractures in the Netherlands between 2000 and 2019: a nationwide study

    Cohort studyBone & mineral

  38. Osteoporos Int

    Reducing diagnostic delay in hypophosphatasia: a case series of 14 patients presenting to general rheumatology

    Cohort studyBone & mineral

  39. Osteoporos Int

    Longitudinal changes in bone mineral density during perimenopausal transition: the Vietnam Osteoporosis Study

    Cohort studyBone & mineral

  40. Osteoporos Int

    The effect of pregnancy vitamin D supplementation on offspring bone mineral density in childhood: a systematic review and meta-analysis

    Meta-analysisBone & mineral

All 695 Briefs in ExploreShowing Briefs 561–600 of 695, newest first